Indications and uses
To use: Apply liberally as often as necessary.
To use: Apply liberally as often as necessary.
This fragrance free version of the legendary skincare classic works wonders to moisturize and protect anytime, anyway you choose. Shape brows, revitalize shine, soothe dry hands and smooth cuticles and nails.
To use: Apply liberally as often as necessary.
Warnings: For external use only. When using this product avoid contact with eyes. Do not apply over puncture wounds, infections or lacerations. Stop using and ask a doctor if symptoms persists more than 7 days.
Active Ingredient: Petrolatum 56.8%
LANOLIN, MINERAL OIL/PARAFFINUM LIQUIDUM/HUILE MINÉRALE, ACACIA DECURRENS EXTRACT, DIPTERYX ODORATA BEAN EXTRACT, VANILLIN, TOCOPHEROL, TOCOPHERYL ACETATE, BHT, SALICYLIC ACID, RICINUS COMMUNIS (CASTOR) SEED OIL, VEGETABLE OIL/OLUS/HUILE VÉGÉTALE, ZEA MAYS (CORN) OIL, BENZYL ALCOHOL, IRON OXIDES.
Apply liberally.
Keep out of reach of children.
Skin protectant.
Avoid contact with eyes. Do not apply over puncture wounds, infections or lacerations.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67938-1149-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3070-f424-e053-dadaa90a57ce | BC1149 |
| 67938-1149-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3070-f424-e053-dadaa90a57ce | BC1149 |
| 67938-1149-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3070-f424-e053-dadaa90a57ce | BC1149 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67938-1149-1 | EIGHT HOUR CREAM SKIN PROTECTANT FRAGRANCE FREE | 1 in 1 BOX | CREAM | 1 | 1 | |
| 67938-1149-2 | EIGHT HOUR CREAM SKIN PROTECTANT FRAGRANCE FREE | 50 g in 1 TUBE | CREAM | 50 | 1 | |
| 67938-1149-3 | EIGHT HOUR CREAM SKIN PROTECTANT FRAGRANCE FREE | 2 g in 1 PACKET | CREAM | 2 | 1 | |
| 67938-1149-4 | EIGHT HOUR CREAM SKIN PROTECTANT FRAGRANCE FREE | 1 in 1 BOX | CREAM | 1 | 1 | |
| 67938-1149-5 | EIGHT HOUR CREAM SKIN PROTECTANT FRAGRANCE FREE | 28 g in 1 TUBE | CREAM | 28 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67938-1149 | EIGHT HOUR CREAM SKIN PROTECTANT FRAGRANCE FREE (PETROLATUM) CREAM [ELIZABETH ARDEN, INC] | 1 | Legacy NDC, 5 package rows | 20111011_afa8c6d1-2a26-4506-8f3e-35a2a22dcfcc.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PETROLATUM | ACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| PETROLATUM | ACTIVE MOIETY | 4T6H12BN9U | 1 | |
| LANOLIN | INACTIVE INGREDIENT | 7EV65EAW6H | 1 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 1 | |
| SALICYLIC ACID | INACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| VANILLIN | INACTIVE INGREDIENT | CHI530446X | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 67938-1149 | 67938-1149-2, 67938-1149-1, 67938-1149-3, 67938-1149-5, 67938-1149-4 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PETROLATUM | 4T6H12BN9U | ACTIB |
| LANOLIN | 7EV65EAW6H | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| VANILLIN | CHI530446X | IACT |
| SALICYLIC ACID | O414PZ4LPZ | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / RECTAL | 105 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, EXTENDED RELEASE / ORAL | 3.4 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, FILM COATED / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| VANILLIN | VANILLIN | CHI530446X | ELIXIR / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET / ORAL | 12 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| VANILLIN | VANILLIN | CHI530446X | POWDER, FOR SUSPENSION / ORAL | 2 mg/1ml | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 1 mg | ||
| VANILLIN | VANILLIN | CHI530446X | SYRUP / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CAPSULE / ORAL | 120 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, DELAYED RELEASE / ORAL | 6 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, FILM COATED / ORAL | 5 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / OPHTHALMIC | 59.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | CREAM / VAGINAL | 2 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / OPHTHALMIC | 3 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, CHEWABLE / ORAL | 6 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | CREAM / TOPICAL | 10 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, CHEWABLE / ORAL | 2.5 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, ORALLY DISINTEGRATING / ORAL | 0.26 mg | ||
| VANILLIN | VANILLIN | CHI530446X | OINTMENT / TOPICAL | NA | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | SHAMPOO / TOPICAL | 2 %w/w | ||
| VANILLIN | VANILLIN | CHI530446X | SOLUTION / ORAL | 2.5 mg/5ml | ||
| VANILLIN | VANILLIN | CHI530446X | SUSPENSION / ORAL | 6 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / AURICULAR (OTIC) | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | SPRAY / NASAL | NA | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | LOTION / TOPICAL | 1.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| VANILLIN | VANILLIN | CHI530446X | LIQUID / ORAL | NA | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, COATED / ORAL | 65.5 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, DELAYED RELEASE / ORAL | 5.67 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | OINTMENT / TOPICAL | 10 %w/w | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | EMULSION / TOPICAL | 0.25 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9f78a938-c8af-460d-ae67-e75a5b1f6ad6 | afa8c6d1-2a26-4506-8f3e-35a2a22dcfcc | 2011-10-04 | Warnings | 9f78a938-c8af-460d-ae67-e75a5b1f6ad6 afa8c6d1-2a26-4506-8f3e-35a2a22dcfcc |
Adverse event summaries are temporarily unavailable. Other product information remains available.